Page last updated: 2024-10-21

edelfosine and Urinary Bladder Neoplasms

edelfosine has been researched along with Urinary Bladder Neoplasms in 3 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinestel, K1
Eder, S1
Ehinger, K1
Schneider, J1
Genze, F1
Winkler, E1
Wardelmann, E1
Schrader, AJ1
Steinestel, J1
Droller, MJ1
Slaton, JW1
Hampton, JA1
Selman, SH1

Other Studies

3 other studies available for edelfosine and Urinary Bladder Neoplasms

ArticleYear
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Adult; Aged; Calcium; Carcinoma; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Huma

2016
This month in Investigative Urology. A commentary on suramin demonstrates in vitro toxicity against transitional cell carcinoma cell lines and exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma.
    The Journal of urology, 1994, Volume: 152, Issue:5 Pt 1

    Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Screening Assays, Antitumor; Humans; Neopl

1994
Exposure to alkyllysophospholipids inhibits in vitro invasion of transitional cell carcinoma.
    The Journal of urology, 1994, Volume: 152, Issue:5 Pt 1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Screening Assays, Antitumor; Huma

1994